SCHRODER INVESTMENT MANAGEMENT GROUP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 63 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2017$350,000
+25.9%
101,463
-8.5%
0.00%0.0%
Q2 2017$278,000
-53.7%
110,939
-50.0%
0.00%0.0%
Q1 2017$600,000
+86.3%
221,878
+100.0%
0.00%0.0%
Q4 2016$322,000
-29.4%
110,9390.0%0.00%0.0%
Q3 2016$456,000
+29.9%
110,9390.0%0.00%0.0%
Q2 2016$351,000110,9390.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 6,552,068$14,218,0008.03%
Versant Venture Management, LLC 5,068,233$10,998,0004.55%
K2 PRINCIPAL FUND, L.P. 1,653,874$3,589,0000.29%
RTW INVESTMENTS, LP 7,483,757$16,240,0000.24%
Avoro Capital Advisors LLC 6,950,000$15,082,0000.24%
Artal Group S.A. 3,000,000$6,510,0000.15%
ALGERT GLOBAL LLC 231,490$502,0000.07%
Virtus ETF Advisers LLC 57,768$125,0000.06%
Pinz Capital Management, LP 53,600$116,0000.05%
TWIN FOCUS CAPITAL PARTNERS, LLC 100,000$217,0000.05%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders